![]() Neurocrine Biosciences Neurocrine Biosciences is a biotechnology company focused on neurologic, psychiatric and endocrine-related disorders. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1992 | Founding Date 1935 | Founding Date 1904 | Founding Date 1928 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 70020% increase | Employees 27,764 | Employees 7,5692% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) 11.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $2.9b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $52.1m (FY, 2025) | Cost of goods ₹97.2b (FY, 2026) | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $2.8b (FY, 2025) | Gross profit ₹184.4b (FY, 2026) | Gross profit $4.5b (FY, 2020) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $478.6m (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income N/A | Net income €1.6b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries N/A | Countries 100 (Dec, 2020) | Countries 35 (FY, 2019) |

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company